News Releases

Press Releases

  • 6/22/16 7:00 am EDT

    - Device designed to revolutionize treatment of Carpal Tunnel Syndrome -

    - Completely percutaneous procedure would replace invasive surgery -

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq:PAVMU), an innovative multi-product medical device company, today announced the successful completion of a pre-clinical human cadaver study, demonstrating that the Company’s completely percutaneous CarpX™ device reliably and effectively transects the ligament which causes Carpal Tunnel Syndrome (CTS). Lishan Aklog, M.D., Chairman and CEO of PAVmed, said “We are excited to report that CarpX performed very well in thismore...
  • 5/26/16 4:05 pm EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq:PAVMU), an innovative, multi-product medical device company developing and commercializing a diversified pipeline of innovative products utilizing a groundbreaking business model focused on capital efficiency and speed to market, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the 2016 Marcum MicroCap Conference on Thursday, June 2, 2016, at 3:30pm ET taking place in Newmore...
  • 5/13/16 9:03 pm EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq:PAVMU), a multi-product medical device company organized to conceive, develop and commercialize a diversified pipeline of innovative products, today announced results for the first quarter, ended March 31, 2016. “During the quarter, we made considerable progress on our five lead products and many other corporate objectives. This culminated with us completing our Initial Public Offering (“IPO”) this past Aprilmore...
  • 4/28/16 2:00 pm EDT

    - Units to Begin Trading Today on Nasdaq Under the Ticker Symbol “PAVMU”-

    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. announced today that it has completed its initial public offering of 1,060,000 units. Each unit consists of one share of common stock and one warrant. The units were sold at an offering price of $5.00 per unit, generating gross proceeds of $5.3 million. The units will begin trading today on the Nasdaq Capital Market under the ticker symbol “PAVMU”. Once the securities comprising the units begin separate trading, the common stock andmore...

SEC Filings

Click Here to view PAVMed's SEC filings


Click Here to view PAVmed’s current Investor Presentation